# A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

> **NCT02836600** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 11 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** LY3039478

## Key facts

- **NCT ID:** NCT02836600
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-09
- **Primary completion:** 2019-07-05
- **Final completion:** 2023-05-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836600, "A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02836600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*